药物诱导的骨折:查和治疗策略
Laraib Javed1, Aemen Khakwani1, Uzair Khan1
1Department of Medicine, University of Oklahoma, College of Medicine, USA.
The American journal of the medical sciences
|August 30, 2024
概括
药物诱导的骨质疏松症越来越令人担忧,特别是在葡萄皮质激素和其他常见药物. 本综述涵盖了这些药物的骨折风险和管理策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
背景情况:
- 药物诱导的骨质疏松症是骨折的重要原因,特别是在老年人群中使用多种药物治疗.
- 葡萄糖皮质类药物是最常见的药物类别,与药物相关的骨折有关.
- 许多其他药物与骨折风险增加有关.
研究的目的:
- 审查与各种药物相关的骨折风险的最新证据.
- 讨论药物诱导骨质疏松症和骨折的查和管理策略.
主要方法:
- 关于药物相关骨折风险的现有证据的文献综述.
- 分析与骨质疏松症和骨折有关的常见药物类别.
- 讨论临床管理和查方案.
主要成果:
- 葡萄糖皮质类药物是药物诱导的骨质疏松症和骨折的主要原因.
- 广泛的其他药物,包括循环利尿剂,SGLT2抑制剂和SSRI,也会增加骨折风险.
- 有证据支持需要主动查和管理.
结论:
- 药物诱导的骨质疏松症对公众健康构成重大挑战.
- 识别和管理各种药物风险的患者至关重要.
- 更新的证据和管理策略对于减轻骨折发病率至关重要.
相关概念视频
Fractures: Bone Repair
3.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.0K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K


